Welcome To The Immunogen HUB On AGORACOM
Developing targeted anticancer therapeutics using our expertise in cancer biology, engineered antibodies and highly potent cancer-cell killing agents.
fast facts
- name Immunogen
- symbol IMGN
- exchange OTCBB
- financials View Filings
- shares outstanding 57 M F/D
- industry Technology & Medical
- transfer agent Mellon Investor Services
- website http://www.immunogen.com
most recent messages
top rated messages